MPAM
Monarch Partners Asset Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.01M | Sell |
170,195
-18,436
| -10% | -$434K | 1.18% | 21 |
|
|
2022
Q3 | $4.92M | Buy |
188,631
+55,589
| +42% | +$1.45M | 1.48% | 7 |
|
|
2022
Q2 | $2.92M | Sell |
133,042
-23,460
| -15% | -$515K | 0.82% | 47 |
|
|
2022
Q1 | $7.02M | Buy |
156,502
+41,838
| +36% | +$1.88M | 1.57% | 3 |
|
|
2021
Q4 | $4.92M | Sell |
114,664
-47,804
| -29% | -$2.05M | 1% | 22 |
|
|
2021
Q3 | $10.8M | Buy |
162,468
+8,581
| +6% | +$571K | 1.58% | 3 |
|
|
2021
Q2 | $11.3M | Buy |
153,887
+140,227
| +1,027% | +$10.3M | 1.62% | 3 |
|
|
2021
Q1 | $935K | Sell |
13,660
-65,272
| -83% | -$4.47M | 0.14% | 137 |
|
|
2020
Q4 | $5.3M | Sell |
78,932
-17,922
| -19% | -$1.2M | 0.93% | 43 |
|
|
2020
Q3 | $4.98M | Buy |
96,854
+74,039
| +325% | +$3.81M | 1.12% | 30 |
|
|
2020
Q2 | $860K | Buy |
22,815
+7,415
| +48% | +$280K | 0.21% | 101 |
|
|
2020
Q1 | $459K | Buy |
15,400
+5,230
| +51% | +$156K | 0.16% | 117 |
|
|
2019
Q4 | $350K | Sell |
10,170
-6,420
| -39% | -$221K | 0.08% | 167 |
|
|
2019
Q3 | $300K | Buy |
+16,590
| New | +$300K | 0.05% | 164 |
|